1. Home
  2. XNCR vs PKST Comparison

XNCR vs PKST Comparison

Compare XNCR & PKST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • PKST
  • Stock Information
  • Founded
  • XNCR 1997
  • PKST 2008
  • Country
  • XNCR United States
  • PKST United States
  • Employees
  • XNCR N/A
  • PKST N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • PKST Real Estate Investment Trusts
  • Sector
  • XNCR Health Care
  • PKST Real Estate
  • Exchange
  • XNCR Nasdaq
  • PKST Nasdaq
  • Market Cap
  • XNCR 579.3M
  • PKST 474.0M
  • IPO Year
  • XNCR 2013
  • PKST N/A
  • Fundamental
  • Price
  • XNCR $7.90
  • PKST $13.29
  • Analyst Decision
  • XNCR Buy
  • PKST Buy
  • Analyst Count
  • XNCR 7
  • PKST 2
  • Target Price
  • XNCR $27.50
  • PKST $15.50
  • AVG Volume (30 Days)
  • XNCR 800.2K
  • PKST 162.4K
  • Earning Date
  • XNCR 08-04-2025
  • PKST 08-07-2025
  • Dividend Yield
  • XNCR N/A
  • PKST 6.75%
  • EPS Growth
  • XNCR N/A
  • PKST N/A
  • EPS
  • XNCR N/A
  • PKST N/A
  • Revenue
  • XNCR $127,228,000.00
  • PKST $225,817,000.00
  • Revenue This Year
  • XNCR N/A
  • PKST N/A
  • Revenue Next Year
  • XNCR $28.84
  • PKST N/A
  • P/E Ratio
  • XNCR N/A
  • PKST N/A
  • Revenue Growth
  • XNCR N/A
  • PKST 5.64
  • 52 Week Low
  • XNCR $7.16
  • PKST $9.89
  • 52 Week High
  • XNCR $27.24
  • PKST $16.26
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 44.24
  • PKST 60.50
  • Support Level
  • XNCR $7.88
  • PKST $12.80
  • Resistance Level
  • XNCR $8.80
  • PKST $13.55
  • Average True Range (ATR)
  • XNCR 0.53
  • PKST 0.41
  • MACD
  • XNCR -0.05
  • PKST -0.01
  • Stochastic Oscillator
  • XNCR 22.41
  • PKST 63.67

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About PKST Peakstone Realty Trust

Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets in majorly high-growth coastal and sunbelt markets. The company has two reportable segments: Industrial and Office. The Industrial segment consists of industrial outdoor storage properties which have a low building-to-land ratio, or low coverage, maximizing yard space for the display, movement, and storage of materials and equipment. The Office segment includes office, R&D and data center properties.

Share on Social Networks: